Exploring Old Drugs for the Treatment of Hematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|10|1509-1514

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.10, 2011-04, pp. : 1509-1514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies

By  

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1757-1764

Bentham Science Publishers

Access to resources Recommend Favorite

MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

By  

Current Cancer Drug Targets, Vol. 15, Iss. 1, 2015-01 ,pp. : 53-70

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2075-2084

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 823-833

Bentham Science Publishers

Access to resources Recommend Favorite